D-0516-2017 Class III Terminated
FDA drug recall D-0516-2017 was initiated by Pfizer Inc. on Nov 22, 2016 and is designated Class III. Reason for recall: Subpotent Drug: Out of Specification (OOS) for potency at the 6-month stability time point. The recall status is terminated (terminated Jun 22, 2018). Affected quantity: 582,165 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 22, 2017
- Initiation Date
- Nov 22, 2016
- Termination Date
- Jun 22, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 582,165 vials
Product description
PROTONIX I.V. (pantoprazole sodium) for Injection, Equivalent to 40 mg pantoprazole per vial, For I.V. infusion only, Rx Only, Distributed by Wyeth Pharmaceuticals Inc, A subsidiary of Pfizer Inc, Philadelphia, PA 19101, Under license from Takeda GmbH, D78467 Konstanz, Germany, MADE IN FRANCE; packaged in A) Pfizer Injectables, 1 vial per carton (NDC 0008-0923-51) in a) bundles of 10 unit cartons (NDC 0008-0923-55) and b) 25 x 40 mg Vials per carton (NDC 0008-0923-60); B) NOVAPLUS, 1 vial per carton (NDC 00008-0941-01) in 25 x 40 mg Vials per carton (NDC 0008-0941-03); and C) PREMIERPro Rx, 1 vial per carton (NDC 0008-4001-01) in a) bundles of 10 unit cartons (NDC 0008-4001-10) and b) 25 x 40 mg Vials per carton (NDC 0008-4001-25).
Reason for recall
Subpotent Drug: Out of Specification (OOS) for potency at the 6-month stability time point.
Distribution pattern
Nationwide
Code information
Lot #: A) a) 325449, Exp 12/16; b) N97969, N69175, N69177, Exp 03/17; N95727, Exp 04/17; B) M51076, Exp 11/16; and C) a) 317364, Exp 11/16; b) N73763, Exp 03/17
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0516-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026